Evolent Health, Inc. (EVH)
USD 10.69
(7.44%)
USD 10.69
(7.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -71.21 Million USD | -19.01% |
| 2022 | -59.83 Million USD | -297.81% |
| 2021 | 30.24 Million USD | 179.85% |
| 2020 | -37.88 Million USD | 68.54% |
| 2019 | -120.4 Million USD | -153.6% |
| 2018 | -47.48 Million USD | 34.82% |
| 2017 | -72.84 Million USD | 69.32% |
| 2016 | -237.41 Million USD | -452.5% |
| 2015 | -42.97 Million USD | -70.21% |
| 2014 | -25.24 Million USD | -19.34% |
| 2013 | -21.15 Million USD | -7.83% |
| 2012 | -19.61 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 9.45 Million USD | 62.29% |
| 2024 Q1 | 5.82 Million USD | 127.3% |
| 2023 Q2 | -21.56 Million USD | -1107.61% |
| 2023 Q4 | -21.35 Million USD | -19.02% |
| 2023 FY | -71.21 Million USD | -19.01% |
| 2023 Q3 | -17.93 Million USD | 16.83% |
| 2023 Q1 | -1.78 Million USD | 90.88% |
| 2022 FY | -59.83 Million USD | -297.81% |
| 2022 Q2 | -1.36 Million USD | -132.63% |
| 2022 Q3 | 12.95 Million USD | 1051.58% |
| 2022 Q1 | 4.17 Million USD | 134.15% |
| 2022 Q4 | -19.57 Million USD | -251.17% |
| 2021 Q3 | -6.58 Million USD | 14.21% |
| 2021 Q4 | -12.21 Million USD | -85.59% |
| 2021 Q1 | -15.94 Million USD | -236.68% |
| 2021 Q2 | -7.67 Million USD | 51.89% |
| 2021 FY | 30.24 Million USD | 179.85% |
| 2020 Q3 | -17.7 Million USD | 92.22% |
| 2020 Q2 | -227.46 Million USD | -792.04% |
| 2020 FY | -37.88 Million USD | 68.54% |
| 2020 Q4 | -4.73 Million USD | 73.26% |
| 2020 Q1 | -25.5 Million USD | 88.12% |
| 2019 FY | -120.4 Million USD | -153.6% |
| 2019 Q1 | -46.64 Million USD | -249.36% |
| 2019 Q4 | -214.59 Million USD | -965.62% |
| 2019 Q3 | -20.13 Million USD | 20.19% |
| 2019 Q2 | -25.23 Million USD | 45.91% |
| 2018 FY | -47.48 Million USD | 34.82% |
| 2018 Q4 | -13.35 Million USD | -21.05% |
| 2018 Q2 | -8.96 Million USD | 36.56% |
| 2018 Q1 | -14.13 Million USD | 22.56% |
| 2018 Q3 | -11.03 Million USD | -23.02% |
| 2017 FY | -72.84 Million USD | 69.32% |
| 2017 Q4 | -18.24 Million USD | -30.16% |
| 2017 Q3 | -14.02 Million USD | 26.66% |
| 2017 Q2 | -19.11 Million USD | 10.9% |
| 2017 Q1 | -21.45 Million USD | 36.66% |
| 2016 Q1 | -175.17 Million USD | -1134.7% |
| 2016 FY | -237.41 Million USD | -452.5% |
| 2016 Q4 | -33.87 Million USD | -113.86% |
| 2016 Q3 | -15.83 Million USD | -25.42% |
| 2016 Q2 | -12.62 Million USD | 92.79% |
| 2015 FY | -42.97 Million USD | -70.21% |
| 2015 Q2 | -11.53 Million USD | 40.36% |
| 2015 Q3 | -17.24 Million USD | -49.46% |
| 2015 Q4 | -14.18 Million USD | 17.73% |
| 2015 Q1 | -19.34 Million USD | -80.85% |
| 2014 Q3 | -3.16 Million USD | 46.67% |
| 2014 Q2 | -5.93 Million USD | 49.0% |
| 2014 Q4 | -10.69 Million USD | -237.8% |
| 2014 Q1 | -11.64 Million USD | -1751.63% |
| 2014 FY | -25.24 Million USD | -19.34% |
| 2013 FY | -21.15 Million USD | -7.83% |
| 2013 Q4 | 705 Thousand USD | 0.0% |
| 2012 FY | -19.61 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Well Corporation | -692.14 Million USD | 89.712% |
| Doximity, Inc. | 163.87 Million USD | 143.454% |
| MultiPlan Corporation | 173.4 Million USD | 141.067% |
| Phreesia, Inc. | -131.77 Million USD | 45.959% |
| Teladoc Health, Inc. | -248.55 Million USD | 71.35% |
| Veeva Systems Inc. | 429.33 Million USD | 116.586% |